(RXI) iShares Global Consumer - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US4642887453 • Consumer Cyclical

RXI: Retail, Restaurants, Hotels, Leisure, Entertainment, Travel

The iShares Global Consumer Discretionary ETF (NYSE ARCA:RXI) is an exchange-traded fund designed to track the performance of the consumer discretionary sector on a global scale. The fund typically allocates at least 80% of its assets to securities included in its underlying index or to investments that exhibit economic characteristics closely aligned with those securities. The underlying index employs a capping methodology to ensure that no single issuers securities exceed a 10% weighting in the index, as determined by S&P Dow Jones Indices LLC. This approach is intended to mitigate concentration risk and promote diversification within the fund. For more information, visit http://www.ishares.com.

Ticker Symbol: RXI | Exchange: NYSE ARCA | Type: ETF | Country Origin: USA | ETF Category: Consumer Cyclical.

Based on the provided data, the funds technical profile indicates that it is currently trading near its short- and medium-term moving averages, with a last price of 189.15, slightly below its 20-day SMA of 191.55 but above its 50-day SMA of 188.93. The 200-day SMA of 173.22 suggests the fund has been in an upward trend over the longer term. The Average True Range (ATR) of 2.07 indicates moderate volatility. The funds assets under management (AUM) of $261.42 million reflect its size within the consumer cyclical ETF category.

3-Month Forecast:

Over the next three months, the funds performance is expected to remain closely tied to the broader consumer discretionary sector. Technically, the funds price is likely to oscillate near its current levels, with potential resistance around the 20-day SMA of 191.55 and support near the 50-day SMA of 188.93. A breakout above 191.55 could signal further upside, while a breach below 188.93 may indicate a near-term downtrend. Fundamentally, the consumer discretionary sectors performance will depend on macroeconomic conditions, consumer spending trends, and corporate earnings. The funds AUM of $261.42 million suggests moderate liquidity, which could impact its price action during periods of high volatility.

Additional Sources for RXI ETF

RXI ETF Overview

Market Cap in USD 220m
Category Consumer Cyclical
TER 0.41%
IPO / Inception 2006-09-12

RXI ETF Ratings

Growth Rating 53.1
Fundamental -
Dividend Rating 52.7
Rel. Strength 0.63
Analysts -
Fair Price Momentum 154.09 USD
Fair Price DCF -

RXI Dividends

Dividend Yield 12m 1.15%
Yield on Cost 5y 1.97%
Annual Growth 5y 14.31%
Payout Consistency 90.9%

RXI Growth Ratios

Growth Correlation 3m -81%
Growth Correlation 12m 80.8%
Growth Correlation 5y 47.6%
CAGR 5y 11.17%
CAGR/Max DD 5y 0.31
Sharpe Ratio 12m 0.37
Alpha 0.44
Beta 1.200
Volatility 38.11%
Current Volume 1.2k
Average Volume 20d 8.1k
What is the price of RXI stocks?
As of April 16, 2025, the stock is trading at USD 170.62 with a total of 1,209 shares traded.
Over the past week, the price has changed by +8.65%, over one month by -5.97%, over three months by -7.70% and over the past year by +8.61%.
Is iShares Global Consumer a good stock to buy?
Partly, yes. Based on ValueRay Analyses, iShares Global Consumer (NYSE ARCA:RXI) is currently (April 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 53.09 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RXI as of April 2025 is 154.09. This means that RXI is currently overvalued and has a potential downside of -9.69%.
Is RXI a buy, sell or hold?
iShares Global Consumer has no consensus analysts rating.
What are the forecast for RXI stock price target?
According to ValueRays Forecast Model, RXI iShares Global Consumer will be worth about 172.4 in April 2026. The stock is currently trading at 170.62. This means that the stock has a potential upside of +1.07%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 172.4 1.1%